⌕
Illumina · ILMN · Nasdaq
Tenet 52 · Mixed
Compare
$202.61+2.33%At closeTenet 52 · Mixed
$202.61+4.61 (+2.33%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
$204.00+1.39 (+0.69%)
After hours: Nov 17, 2026, 6:51 PM ET

Illumina (ILMN) Stock

Illumina (ILMN) closed at $202.61 on Nov 17, 2026; its Tenet Score is 52 of 100 against 340 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

6 figures withheld by our checks. Each blank figure names its reason.

Key stats

Close
$202.61
Nov 17, 2026
Market cap
$29.9B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
34.1×
TTM through Sep 27, 2026 · as of close, Nov 16, 2026
52-week range
112.65 – 309.35
low → high · as of close, Nov 16, 2026
Tenet Score
52/100
Mixed · 340 Healthcare peers

Industry: Drugs

Illumina Inc scores 52/100. Mixed. Strongest on quality, value is the soft spot, trading at 34× earnings versus 340 Healthcare peers.

Tenet Score · vs sector

n=340
52/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
35
Quality
73
Health
48
Growth
49

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueDQualityBHealthDGrowthDMomentumA+
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
9.5×
Sep 27, 2026 balance sheet
P/S
6.6×
price to sales, TTM through Sep 27, 2026 · as of close, Nov 16, 2026
ROE
32%
TTM through Sep 27, 2026
Operating margin
18.6%
fiscal 2025, before interest and tax
Net margin
19.7%
TTM through Sep 27, 2026
Current ratio
2.63
Sep 27, 2026 balance sheet
Net debt / EBITDA
0.4×
TTM through Sep 27, 2026
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Illumina Inc

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in t…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=340) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 325 US ETFs · top wrappers by weightSee all ETFs holding ILMN →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 16, 2026.

Compare Illumina with

What sector and industry is Illumina in?

Illumina is in the Healthcare sector and the Drugs industry.

What is Illumina's Tenet Score?

Illumina's Tenet Score is 52 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.